Cargando…
Past, present, and future of three‐field lymphadenectomy for thoracic esophageal cancer
In spite of repeated appeal of the effectiveness of three‐field lymphadenectomy (3FL) by Japanese esophageal surgeons, it has not been accepted worldwide as a standard therapeutic measure for thoracic esophageal cancer. In this review, a concise summary of the history of 3FL, its present position, a...
Autor principal: | Udagawa, Harushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382429/ https://www.ncbi.nlm.nih.gov/pubmed/32724875 http://dx.doi.org/10.1002/ags3.12338 |
Ejemplares similares
-
Advantageous factors of R0 curative conversion esophagectomy and the optimal extent of lymphadenectomy after induction therapy for cT4b thoracic esophageal cancer
por: Ohkura, Yu, et al.
Publicado: (2020) -
Comment on “Prognosis of Patients With Esophageal Carcinoma Following Routine Thoracic Duct Resection: A Propensity-Matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan”
por: Udagawa, Harushi
Publicado: (2023) -
Thoracoscopic esophagectomy with three-field lymphadenectomy for thoracic esophageal cancer in a patient with a double aortic arch: a report of a case
por: Fujiwara, Hisashi, et al.
Publicado: (2019) -
Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis
por: Li, Kexun, et al.
Publicado: (2023) -
The fields of HIV and disability: past, present and future
por: Hanass-Hancock, Jill, et al.
Publicado: (2009)